Why weight-loss drugs may be no obesity silver bullet/in /by
Ministers are lauding the new generation of weight-loss drugs - but are they really the solution?
This young disabled man dreamed of having a job – the system had other ideas/in /by
Elliot wants to live independently - but making that happen proved a bigger challenge than he expected.
‘I’m too tired to chew food but still can’t get care for my ME’/in /by
What is NHS care like for people with severe ME, also known as chronic fatigue syndrome?
Will I be diagnosed with Alzheimer’s like my mother?/in /by
Broadcaster Sally Magnusson faces the dilemma of whether to take part in research that could indicate if she is likely to develop the condition.
‘I nearly died drinking a ginger beer – my school’s EpiPen saved my life’/in /by
Campaigners want businesses to have EpiPens on hand to treat people having dangerous allergic reactions.
Covid inquiry told of trust do-not-resuscitate rule/in /by
Patients' families were “horrified but not surprised” when told the blanket policy had been in place.
Covid inquiry told of trust do-not-resuscitate rule/in /by
Patients' families were “horrified but not surprised” when told the blanket policy had been in place.
UK firm GSK to pay $2.2bn over Zantac cancer claims/in /by
The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants.
UK firm GSK to pay $2.2bn over Zantac cancer claims/in /by
The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants.
UK firm GSK to pay $2.2bn over Zantac cancer claims/in /by
The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants.